BACKGROUND: Few studies have examined recent temporal trends in self-reported receipt of pelvic inflammatory disease (PID) treatment. We assessed trends in receipt of PID treatment and associated correlates using national survey data. METHODS: We used data from the National Survey of Family Growth, a multistage national probability survey of 15- to 44-year-old women. We examined trends in self-reported receipt of PID treatment from 1995, 2002, to 2006-2010. In addition, we examined correlates of PID treatment in 1995 and 2006-2010 in bivariate and adjusted analyses. RESULTS: From 1995 to 2002, receipt of PID treatment significantly declined from 8.6% to 5.7% (P < 0.0001); however, there was no difference from 2002 to 2006-2010 (5.0%, P = 0.16). In bivariate analyses, racial differences in PID treatment declined across time; in 2006-2010, there was no significant difference between racial/ethnic groups (P = 0.22). Also in bivariate analyses, similar to 1995, in 2006 to 2010, some of the highest reports of receipt of PID treatment were women who were 35 to 44 years old (5.6%), had an income less than 150% of poverty level (7.5%), had less than high school education (6.7%), douched (7.7%), had intercourse before age 15 years (10.3%), and had 10 or more lifetime partners (8.0%). In adjusted analyses, differing from 1995, women at less than 150% of the poverty level were more likely (adjusted odds ratio [AOR], 2.60; 95% confidence interval [CI], 1.79-3.76) than women at 300% or more of the poverty level to have received PID treatment in 2006-2010. CONCLUSIONS: Receipt of PID treatment declined from 1995 to 2006-2010, with the burden affecting women of lower socioeconomic status.
BACKGROUND: Few studies have examined recent temporal trends in self-reported receipt of pelvic inflammatory disease (PID) treatment. We assessed trends in receipt of PID treatment and associated correlates using national survey data. METHODS: We used data from the National Survey of Family Growth, a multistage national probability survey of 15- to 44-year-old women. We examined trends in self-reported receipt of PID treatment from 1995, 2002, to 2006-2010. In addition, we examined correlates of PID treatment in 1995 and 2006-2010 in bivariate and adjusted analyses. RESULTS: From 1995 to 2002, receipt of PID treatment significantly declined from 8.6% to 5.7% (P < 0.0001); however, there was no difference from 2002 to 2006-2010 (5.0%, P = 0.16). In bivariate analyses, racial differences in PID treatment declined across time; in 2006-2010, there was no significant difference between racial/ethnic groups (P = 0.22). Also in bivariate analyses, similar to 1995, in 2006 to 2010, some of the highest reports of receipt of PID treatment were women who were 35 to 44 years old (5.6%), had an income less than 150% of poverty level (7.5%), had less than high school education (6.7%), douched (7.7%), had intercourse before age 15 years (10.3%), and had 10 or more lifetime partners (8.0%). In adjusted analyses, differing from 1995, women at less than 150% of the poverty level were more likely (adjusted odds ratio [AOR], 2.60; 95% confidence interval [CI], 1.79-3.76) than women at 300% or more of the poverty level to have received PID treatment in 2006-2010. CONCLUSIONS: Receipt of PID treatment declined from 1995 to 2006-2010, with the burden affecting women of lower socioeconomic status.
Authors: James M Lepkowski; William D Mosher; Karen E Davis; Robert M Groves; John van Hoewyk; Jennifer Willem Journal: Vital Health Stat 2 Date: 2006-07
Authors: Kwame Owusu-Edusei; Harrell W Chesson; Thomas L Gift; Guoyu Tao; Reena Mahajan; Marie Cheryl Bañez Ocfemia; Charlotte K Kent Journal: Sex Transm Dis Date: 2013-03 Impact factor: 2.830
Authors: S Deblina Datta; Maya Sternberg; Robert E Johnson; Stuart Berman; John R Papp; Geraldine McQuillan; Hillard Weinstock Journal: Ann Intern Med Date: 2007-07-17 Impact factor: 25.391
Authors: Kristen R Moore; Stephen R Cole; Dirk P Dittmer; Victor J Schoenbach; Jennifer S Smith; Donna D Baird Journal: J Womens Health (Larchmt) Date: 2015-04-22 Impact factor: 2.681
Authors: Thomas A Peterman; Kevin O'Connor; Heather M Bradley; Elizabeth A Torrone; Kyle T Bernstein Journal: Sex Transm Dis Date: 2016-12 Impact factor: 2.830
Authors: Christina B Rasmussen; Susanne K Kjaer; Vanna Albieri; Elisa V Bandera; Jennifer A Doherty; Estrid Høgdall; Penelope M Webb; Susan J Jordan; Mary Anne Rossing; Kristine G Wicklund; Marc T Goodman; Francesmary Modugno; Kirsten B Moysich; Roberta B Ness; Robert P Edwards; Joellen M Schildkraut; Andrew Berchuck; Sara H Olson; Lambertus A Kiemeney; Leon F A G Massuger; Steven A Narod; Catherine M Phelan; Hoda Anton-Culver; Argyrios Ziogas; Anna H Wu; Celeste L Pearce; Harvey A Risch; Allan Jensen Journal: Am J Epidemiol Date: 2016-12-09 Impact factor: 4.897
Authors: Andria Apostolou; Christina Chapman; Marissa Person; Kristen Kreisel; Jeffrey McCollum Journal: Am J Public Health Date: 2018-09-25 Impact factor: 9.308
Authors: Gloria E Anyalechi; Harold C Wiesenfeld; Robert D Kirkcaldy; Dmitry M Kissin; Catherine L Haggerty; Karen R Hammond; Edward W Hook; Kyle T Bernstein; Michael P Steinkampf; William M Geisler Journal: Sex Transm Dis Date: 2021-10-01 Impact factor: 3.868